Brainstorm Cell Therapeutics reported $1.02M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Biogen USD 29.44B 232M Dec/2025
Brainstorm Cell Therapeutics USD 1.02M 358K Dec/2025
Cipla INR 401.64B 27.77B Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 156.57M 58.73M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Cytokinetics USD 1.42B 12.02M Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
Grifols EUR 23.15B 142.7M Dec/2025
Halozyme Therapeutics USD 2.53B 304.09M Dec/2025
Mesoblast USD 782.31M 2.38M Dec/2025